MarginsXMarginsX
Home › Markets › Health Care › ACON

Aclarion Inc. (ACON)

ACON trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.39
-12.58% on the day
Market cap
$4.0M
Nano cap
Revenue · 2025
$76K
+65.6% on 2024
Net income · 2025
-$7.2M
-9551.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1635077/000168316826001986/0001683168-26-001986-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerACON on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2022
SEC CIK0001635077
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$76K
Net income-$7.2M
Operating income-$7.1M
Net margin-9551.9%
Operating margin-9312.5%
Revenue growth+65.6%
Cash$12.0M
Total assets$13.7M
P/E (computed)Net income was not positive
P/S (computed)52.9×

Warning signs

Cash runway
19.0 months
$14.2M cash at September 30, 2026
Share count, 1 year
+329.3%
2025-11-10 to 2026-11-03 · +4743856.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$177K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$14.2M cash; operating cash flow -$2.2M a quarter.Report 2026-09-30
Shares outstanding2,882,370 (2026-11-03); 671,371 a year earlier; 8,793,010 three years earlier. 3y figure adjusted for splits (1-for-144720 overall).Cover page 2026-11-03
Reverse splits, 3 years3; latest 1-for-27 on 2025-03-28Source 2025-03-28
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-01-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHaynie & Company, Salt Lake City, Utah, United StatesPCAOB Form AP 2026-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $177K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$34K-$2.6M-$2.0M$14.2MNo debt tags$99K10-Q 2026-11-05
Q2 2026
2026-06-30
$25K-$2.7M-$2.7M$16.3MNo debt tags$84K10-Q 2026-08-06
Q1 2026
2026-03-31
$21K-$2.9M-$2.6M$19.0MNo debt tags$78K10-Q 2026-05-13
Q4 2025
2025-12-31
$18K-$1.9M-$1.6M$12.0MNo debt tags$76K10-K 2026-03-18
Q3 2025
2025-09-30
$19K-$1.7M-$1.2M$11.3MNo debt tags$67K10-Q 2026-11-05
Q2 2025
2025-06-30
$19K-$1.6M-$1.9M$12.8MNo debt tags$63K10-Q 2026-08-06
Q1 2025
2025-03-31
$19K-$2.0M-$2.5M$14.8MNo debt tags$55K10-Q 2026-05-13
Q4 2024
2024-12-31
$10K-$2.0M-$923K$454K$0$46K10-K 2026-03-18

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED 5-5-25
424B52026-01-09
Latest annual report
FORM 10-K FOR DEC 2025
10-K2026-03-18
Latest quarterly / interim
FORM 10-Q FOR SEPT 2026
10-Q2026-11-05
Latest current report
CURRENT REPORT
8-K2026-06-04
Latest proxy
NOTICE AND PROXY STATEMENT
DEF 14A2026-04-27

Source: SEC EDGAR submissions feed, 276 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.0%
1 month-27.1%
3 months-35.0%
Year to date-66.1%
1 year-74.6%
From 52-week high-80.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
ACONWAclarion Inc. Warrant$0.0214

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ADVBAdvanced Biomed Inc.$2.22-12.25%$3.7M
ACHAccendra Health Inc.$0.0857-35.08%$6.6M
BGLCBioNexus Gene Lab Corp$0.8200-0.12%$2.4M
AMSAmerican Shared Hospital Services$1.07-0.93%$7.1M
MDXHMDxHealth SA$0.1490+3.40%$14.2M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
XGNExagen Inc.$3.77-8.72%$96.2M
BDSXBiodesix Inc.$9.00-8.91%$99.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier